Therefore, tests detecting PD-L1 expression may play an important role in the use and development of anti PD-1/PD-L1 agents aimed at these tumor types, which include bladder/urothelial cell, lung, gastric, and ovarian cancer. Here, CD274 is linked to neoplasm.